GGrantIndex
Sort

46,585 grants matching heart failure

Stem Cells for Dilated Cardiomyopathy

$639,505
Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2011 · HL

3D Echocardiography to Improve Clinical Outcomes After Surgery for Ischemic Mitral Regurgitation

$639,500
Robert C Gorman · University Of Pennsylvania · R01 · FY2017 · HL

Effects of Vitamin D and Omega 3 Fatty Acids on Incidence Rate of Heart Failure

$639,499
Luc Djousse · Brigham And Women'S Hospital · R01 · FY2017 · HL

Adiponectin in Cardiovascular Biology and Pathology

$639,475
Harvey F Lodish · Massachusetts Institute Of Technology · P01 · FY2010 · HL

Heart Disease in Rheumatoid Arthritis

$639,388
Cynthia S Crowson · Mayo Clinic Rochester · R01 · FY2016 · AR

Identifying and Facilitating Ventricular Recovery on Mechanical Support

$639,258
John Gorcsan · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · HL

PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation

$639,138
Muhammad Ashraf · University Of Cincinnati · R01 · FY2012 · HL

High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy

$639,117
Babak Nazer · University Of Washington · R01 · FY2024 · HL

Randomized Controlled Trial of a Six-Month Mindfulness-Based Intervention for Type 2 Diabetes

$638,945
Nazia T. Raja-Khan · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · DK

Novel therapeutic approaches to Mitral valve repair in ischemic heart disease

$638,921
Sai Muralidhar Padala · Emory University · R01 · FY2019 · HL

Novel therapeutic approaches to Mitral valve repair in ischemic heart disease

$638,920
Sai Muralidhar Padala · Emory University · R01 · FY2018 · HL

Novel therapeutic approaches to Mitral valve repair in ischemic heart disease

$638,920
Sai Muralidhar Padala · Emory University · R01 · FY2020 · HL

Novel therapeutic approaches to Mitral valve repair in ischemic heart disease

$638,920
Robert Allan Guyton · Emory University · R01 · FY2021 · HL

Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment

$638,913
William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2016 · CA

Stem Cells for Dilated Cardiomyopathy

$638,895
Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2014 · HL

Insights into Coronary Microvascular Dysfunction in Diabetic Cardiomyopathy

$638,872
Liya Yin · University Of Arizona · R01 · FY2025 · HL

Somatic TET2 mutations in cardiac remodeling

$638,816
Kenneth Walsh · University Of Virginia · R01 · FY2019 · HL

Somatic TET2 mutations in cardiac remodeling

$638,816
Kenneth Walsh · University Of Virginia · R01 · FY2020 · HL

Nociceptive Afferent Topographical Innervation of the Heart and Stomach

$638,757
Zixi Jack Cheng · University Of Central Florida · U01 · FY2019 · NS

Ex Vivo Induction of Tolerance for Autoimmune Diabetes

$638,696
William Edward Beschorner · Ximerex, Inc. · R43 · FY2009 · DK

Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for Transplantation

$638,627
Paul Tang · Mayo Clinic Rochester · R01 · FY2024 · HL

Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV

$638,591
Jennifer Jao · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · HL

A multifaceted adaptive mobile application to promote self-management and improve outcomes in heart failure

$638,584
Michael Dorsch · University Of Michigan At Ann Arbor · R01 · FY2020 · AG

A mixed-methods study of the nature, extent and consequences of artificial intelligence (AI) for individualized treatment planning in end-of-life and palliative care (EOLPC)

$638,578
Matthew Wayne Decamp · University Of Colorado Denver · R01 · FY2024 · NR

Thromboregulatory strategies to prolong xenograft survival.

$638,482
Simon C Robson · Beth Israel Deaconess Medical Center · U01 · FY2007 · AI